Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients

被引:13
作者
Gao, Zhongyang [1 ]
Zhou, Songlin [2 ,3 ]
Song, Hui [4 ]
Wang, Yiqun [5 ]
He, Xijing [5 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Orthoped Surg, Hangzhou, Peoples R China
[2] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Peoples R China
[3] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China
[5] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 2, 157 Xiwu Rd, Xian 710004, Peoples R China
基金
中国国家自然科学基金;
关键词
cancer-specific survival; chondroblastic osteosarcoma; nomogram; overall survival; surgical resection; HIGH-GRADE OSTEOSARCOMA; PROGNOSTIC-FACTORS; NONMETASTATIC OSTEOSARCOMA; EXTREMITY; CHONDROSARCOMA; CHEMOTHERAPY; VALIDATION; RECURRENCE; SARCOMA; BONE;
D O I
10.1002/jso.26185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The establishment of precise and personalized prediction systems for chondroblastic osteosarcoma patients is important for guiding the treatment. Methods The univariate logrank test and multivariate Cox regression analysis were performed to identify independent prognostic factors for overall survival (OS) and cancer-specific survival (CSS). Nomograms were constructed to estimate the OS and CSS based on these factors. Internal and external validation was performed. The predictive power of the nomograms was determined by C-index and calibration plots. Results A total of 401 chondroblastic osteosarcoma cases were identified. Univariate and multivariate analysis revealed that age at diagnosis, histological grade, tumor size, Surveillance, Epidemiology, and End Results stage, and surgical resection were independent prognostic factors for OS and CSS. The five factors were incorporated to construct the nomograms for estimating the 3- and 5-year OS and CSS. The C-index values for the internal validation of the OS and CSS nomogram were 0.732 and 0.746, respectively, and for the external validation were 0.780 and 0.808, respectively. The calibration curves revealed that the predicted OS and CSS could well match the actual survival rate. Conclusions The nomograms for predicting 3- and 5-year OS and CSS were constructed and were proved to be accurate and reliable by the internal and external validation.
引用
收藏
页码:1676 / 1684
页数:9
相关论文
共 37 条
[1]  
Almeida Etanaiara, 2014, J Oral Maxillofac Pathol, V18, P464, DOI 10.4103/0973-029X.151357
[2]   Survival, Recurrence, and Function After Epiphyseal Preservation and Allograft Reconstruction in Osteosarcoma of the Knee [J].
Aponte-Tinao, Luis ;
Ayerza, Miguel A. ;
Muscolo, D. Luis ;
Farfalli, German L. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2015, 473 (05) :1789-1796
[3]   Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine [J].
Arshi, Armin ;
Sharim, Justin ;
Park, Dony Y. ;
Park, Howard Y. ;
Yazdanshenas, Hamed ;
Bernthal, Nicholas M. ;
Shamie, Arya N. .
SPINE JOURNAL, 2017, 17 (05) :645-655
[4]   Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity - Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor [J].
Bacci, G ;
Bertoni, F ;
Longhi, A ;
Ferrari, S ;
Forni, C ;
Biagini, R ;
Bacchini, P ;
Donati, D ;
Manfrini, M ;
Bernini, G ;
Lari, S .
CANCER, 2003, 97 (12) :3068-3075
[5]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[6]   Tumor size and prognosis in aggressively treated osteosarcoma [J].
Bieling, P ;
Rehan, N ;
Winkler, P ;
Helmke, K ;
Maas, R ;
Fuchs, N ;
Bielack, S ;
Heise, U ;
Jurgens, H ;
Treuner, J ;
Romanowski, R ;
Exner, U ;
Kotz, R ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :848-858
[7]   Long-term Outcome of Chondrosarcoma: A Single Institutional Experience [J].
Bindiganavile, Srimanth ;
Han, Ilkyu ;
Yun, Ji Yeon ;
Kim, Han-Soo .
CANCER RESEARCH AND TREATMENT, 2015, 47 (04) :897-903
[8]  
Camp Robert L, 2004, Clin Cancer Res, V10, P7252
[9]   Therapy for osteosarcoma: Where do we go from here? [J].
Chou A.J. ;
Geller D.S. ;
Gorlick R. .
Pediatric Drugs, 2008, 10 (5) :315-327
[10]   A review of clinical and molecular prognostic factors in osteosarcoma [J].
Clark, Jonathan C. M. ;
Dass, Crispin R. ;
Choong, Peter F. M. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (03) :281-297